Influence of COVID-19 Diabetic Ulcer Treatment Market Share, Scope, Revenue, Trends (2019-2025)

Market Forecast

The Global Diabetic Ulcer Treatment Market is estimated to be USD 7500 Million by 2025 at a CAGR of 8.5%.An increase in healthcare expenditure in developing countries is expected to drive the growth of the global diabetic ulcer treatment market.Strategic mergers & acquisitions are also likely to boost market growth with companies looking to strengthen their market positioning, increase their product portfolios, and improve their brand goodwill. For instance, in May 2019, 3M announced the acquisition of Acelity L.P.Inc.  and its KCI subsidiaries for approximately USD 6.7 billion. The acquisition would help 3M strengthen its position in the global diabetic ulcer treatment market.

Download Sample of This Strategic Report- https://www.kennethresearch.com/sample-request-10159190

Market Influencer

Increased spending on healthcare. Diabetic ulcer treatment accounted for an estimated hospitalization or amputation costs of USD 35,000 to USD 45,000 in Australia, Europe, and the Americas, and around USD 5,000 in developing countries.

Market Drivers

Increasing geriatric population

Rise in the prevalence rate of diabetic foot ulcers. One of the most common complications associated with diabetes is diabetic foot ulcerations. It has a global annual incidence rate of 6.3%.The upsurge in the adoption of technological advancements in wound care products.Rising patient population and advancement in health care infrastructure.The high cost of diabetic ulcer treatments. In 2017, it was estimated that in European countries the direct and indirect expenditure in the care for patients suffering from diabetic foot ulcers is USD 13,561 annually.

Segmentation

By Type

Foot Ulcer: This segment consists of neuropathic ulcers, neuro-ischemic ulcers, and ischemic ulcers. This is the largest segment of the diabetic ulcer treatment market.Mouth Ulcer: This segment is estimated to hold the second-largest share of the market, owing to the high prevalence of mouth ulcer in diabetic patient.

Download Sample of This Strategic Report- https://www.kennethresearch.com/sample-request-10159190

By Treatment

Wound Care Dressings: This segment consists of hydrogels, foams, alginates, and others. This is estimated to be the largest segment of the market, because of the increasing number of diabetic patients and mounting the geriatric population.Wound Care Devices: This segment consists of ultrasound therapy, negative pressure wound therapy device (NPWT), and hyperbaric oxygen therapy (HBOT). This segment is driven by new technological advancements in healthcare.Active Therapies: This segment includes skin grafts and substitutes and topical agents. The topical agents are used for diabetic ulcers, either as a treatment for infected wounds or to prevent infection in uninfected wounds.

By End-User

Hospitals and clinics: This is the largest segment. The government support, favorable policies, and awareness campaigns initiated by governments across the globe are responsible for increasing the number of patients in hospitals and clinics. For instance, in 2016, the Government of India had launched the mDiabetes portal with the help of the World Health Organization (WHO) to spread awareness about diabetes.Ambulatory Surgical Centers: A growing segment owing to an increasing prevalence rate of diabetes and number of surgeries.Academic and Research Organization: Technology advances and research and development collaborations in medical science is driving the growth of the segment.

Request For Full Report- https://www.kennethresearch.com/sample-request-10159190

By Region

Americas: The largest regional market. As per recent reports, 30.3 million people are suffering from diabetes, which is 9.4% of the US population and almost 84.1 million adults aged 18 years or older are suffering from prediabetes, which is 33.9% of the US adult population.Europe: Europe’s 9.6% of GDP was devoted to health care in 2017. In Europe, the total expenditure spent on diabetes treatment in year 2017, was USD 207 billion. Also, the health care segment of the region is well versed, and hence, it is the second-largest market.

Asia-Pacific: The fastest-growing regional market for diabetic ulcer treatment, Asia-Pacific has the world’s largest population and fast-developing healthcare industry such as in China, India, and others. In addition, East Asia has a growing elderly population which is expected to drive the market’s growth.Middle East & Africa: The underdeveloped infrastructural chain of the region makes it very difficult for the manufactures to reach their consumers. However, if the affordability rate improves the growth of the market would be even more dynamic.

Request For Full Report- https://www.kennethresearch.com/sample-request-10159190

Key Players

Smith & Nephew PLC (UK)

Integra LifeSciences Corporation (US)

SANUWAVE Health, Inc. (US)

Cardinal Health (US)

3M (US)

Braun Melsungen AG (Germany)

ACELITY L.P. INC. (US)

ConvaTec Group PLC (UK): Offers advanced wound care under the brand names Aquacel, AVELLE, DuoDERM, Foam Lite, and Hydrofibe

Organogenesis Inc. (US)

Mölnlycke Health Care AB (Sweden)

Essity Aktiebolag (Sweden)

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609

James Bullock is a Research Expert with a demonstrated history of working in the professional training & coaching industry. Strong professional skilled in business strategy , Strategic Planning, Research Strategy, and Marketing. also have interest in new innovations and technology

Leave a Reply